|
Cellerix has developed an autologous adipose stem cell therapy for the treatment of fistulas. This drug has shown safety and preliminary efficacy in phase I studies. However autologous adipose stem cell therapy autologous is also a promising therapeutic approach to overcome the current disadvantages of corneal transplantation.
|
